IL2 and neoplasm: The dysregulation of this pathway promotes tumor cell resistance to Fas-mediated apoptosis and IL-2 signaling-mediated activation of the JAK/STAT, NF-kB and MAPK pathways, leading to tumor cell proliferation and survival [64,65].